KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Other Working Capital Changes (2017 - 2025)

Guardant Health (GH) has disclosed Other Working Capital Changes for 9 consecutive years, with -$9.1 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 509.53% to -$9.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.4 million through Dec 2025, down 17.38% year-over-year, with the annual reading at $6.4 million for FY2025, 17.38% down from the prior year.
  • Other Working Capital Changes hit -$9.1 million in Q4 2025 for Guardant Health, down from $8.2 million in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $16.7 million in Q4 2022 to a low of -$21.8 million in Q3 2022.
  • Historically, Other Working Capital Changes has averaged $543050.0 across 5 years, with a median of $1.2 million in 2023.
  • Biggest five-year swings in Other Working Capital Changes: tumbled 1615.53% in 2021 and later skyrocketed 1449.34% in 2025.
  • Year by year, Other Working Capital Changes stood at -$1.6 million in 2021, then surged by 1158.95% to $16.7 million in 2022, then crashed by 89.37% to $1.8 million in 2023, then crashed by 184.61% to -$1.5 million in 2024, then crashed by 509.53% to -$9.1 million in 2025.
  • Business Quant data shows Other Working Capital Changes for GH at -$9.1 million in Q4 2025, $8.2 million in Q3 2025, and $4.2 million in Q2 2025.